Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma

This study is currently recruiting participants.

Study NCT00474929 Information provided by National Cancer Institute (NCI)

First Received: May 16, 2007 Last Updated: February 3, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2011 (Final data collection date for primary outcome measure)